MEDRx Co., Ltd.
株式会社メドレックス
2002-01-01
TYO
Japan
Drug development based on formulation technology
ILTS®
NCTS®
Microneedle array
431-7 Nishiyama, Higashikagawa City, Kagawa Prefecture, 769-2712, Japan
Yoshiaki Matsumura
50,000,000
21 people
20 people
Company name
Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder

21 entries
DateDescription
2002-01 Established MEDRx Co., Ltd. in Higashikagawa City, Kagawa Prefecture, as a pharmaceutical formulation company developing new dosage forms in response to diversified lifestyles and unprecedented aging society.
2002-01 Founded as MEDRx Co., Ltd
2005-04 Obtained Class I pharmaceutical manufacturing and sales license (License No. 37A1X00003) and Class II pharmaceutical manufacturing and sales license (License No. 37A2X00006).
2005-04 Became Marketing Authorization Holders for Class I & II pharmaceutical products
2005-04 Obtained a license for the manufacturing and sale of first-class pharmaceutical products (License number 37A1X00003) and a license for the manufacturing and sale of second-class pharmaceutical products (License number 37A2X00006).
2005-08 Launched Iodocoat ointment for pressure ulcers and skin ulcers.
2005-08 Launch a sales of Iodocoat (R) Ointment 0.9%
2007-08 Relocated headquarters from Matsubara, Higashikagawa City to Nishiyama, Higashikagawa City.
2007-08 Moving of head office
2007-10 Established subsidiary IL Pharma Inc. in Massachusetts, USA, for clinical development.
2007-10 Established IL Pharma Inc in USA as a subsidiary
2013-02 Listed on the Tokyo Stock Exchange Mothers market.
2013-02 Llisted on Tokyo Stock Exchange Mothers Index
2015-04 Established subsidiary MEDRx USA INC. in California, USA, for clinical development.
2015-04 Established MEDRx USA INC in USA as a subsidiary
2015-10 Merged IL Pharma Inc. into MEDRx USA INC. for centralized and efficient subsidiary management.
2015-10 Merger IL Pharma Inc. and MEDRx USA INC. ,with MEDRx USA as the surviving company
2015-10 Merger IL Pharma Inc. and MEDRx USA INC., with MEDRx USA as the surviving company
2022-04 Transitioned from the Tokyo Stock Exchange Mothers market to the Growth market due to market classification review.
2022-04 Transition to the Growth Market of the Tokyo Stock Exchange.
2024-03 Established MEDRX AUSTRALIA PTY LTD in Australia as a subsidiary
+ Loaded when opened
3470001011509
Trade name株式会社メドレックス
Trade name (kana)メドレックス
Name in English
Corporation type301
Address〒769-2712 香川県東かがわ市西山431番地7
Postal code7692712
Prefecture code37
City code207
Address outside Japan
Prefecture in English
City in English
Address outside Japan in English
Corporate number assignment date2015-10-05
Update date2019-04-11
Change date2015-10-05
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
Latest record1
Excluded from search0
Processing type01
Correction type1
Trade name image ID
Address image ID
Sequence number5049861
Source: National Tax Agency Corporate Number Publication Site, basic three items
3470001011509
Corporate number3470001011509
Trade name株式会社メドレックス
Trade name (kana)メドレックス
Trade name (alphabet)
Registry closure date
Reason for registry closure
Registered address香川県東かがわ市西山431番地7
Postal code7692712
Prefecture香川県
Prefecture code37
City or district東かがわ市
City code207
Street address西山431番地7
Organisation type301
Processing type01
Correction type1
Status
Representative代表取締役社長  松村  米浩
Capital450912000
Employees20
Employees (male)
Employees (female)
Business summary
Website URL
Year founded
Business category
Date established
Unified government qualification - grade
Unified government qualification - business items
Update date2019-04-11
Key information3470001011509
Source: gBizINFO (Ministry of Economy, Trade and Industry)
2026-09-23 01:42 (Model: ggml-org/gpt-oss-20b )
↑